Nemaura Medical, Inc. Common Stock
NMRD
NMRD was delisted on the 4th of January, 2024.
17 hedge funds and large institutions have $3.7M invested in Nemaura Medical, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 3 closing their positions.
62% more capital invested
Capital invested by funds: $2.29M → $3.7M (+$1.41M)
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
0% more funds holding
Funds holding: 17 → 17 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TM
Tiger Management
New York
|
+$1.57M |
| 2 |
AIP
ARS Investment Partners
New York
|
+$63.4K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$21.7K |
| 4 |
State Street
Boston,
Massachusetts
|
+$12.3K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$8.57K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$173K |
| 2 |
MFG
Magnus Financial Group
New York
|
-$62K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$8.09K |
| 4 |
BlackRock
New York
|
-$5.64K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.86K |
NMRD Hedge Fund Activity: Q1 2022 in Review
17 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Nemaura Medical, Inc. Common Stock (NMRD) for Q1 2022, worth a combined $3.7M — up 62% from $2.29M a quarter earlier.
Fund positioning in NMRD was balanced in Q1 2022: 3 funds opened new positions, 3 closed out, 6 added to existing stakes and 5 trimmed.
The largest buyer was Tiger Management, opening a new position worth an estimated $1.57M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $173K sold.
- 17 institutional investors held Nemaura Medical, Inc. Common Stock (NMRD) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $3.7M of Nemaura Medical, Inc. Common Stock stock for Q1 2022, up 62% quarter-over-quarter.
- 3 funds opened new Nemaura Medical, Inc. Common Stock positions in Q1 2022 and 3 closed out, a net change of 0 holders.
- The largest Nemaura Medical, Inc. Common Stock buyer in Q1 2022 was Tiger Management, an estimated $1.57M added.
- The largest Nemaura Medical, Inc. Common Stock seller in Q1 2022 was Renaissance Technologies, an estimated $173K sold.
Based on aggregated 13F filings for Q1 2022.